Anita Groppi

Anita Groppi

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 February 2026 in Medicina
Verified
Journal Article
Open access
PDF file
Federica PulicariFederica Pulicari
Federica Pulicari
Matteo PellegriniMatteo Pellegrini
Matteo Pellegrini
SDSabrina Darwish
Sabrina Darwish
AGAnita Groppi
Anita Groppi
MPMassimo Porrini
Massimo Porrini
FSFrancesco Spadari
Francesco Spadari
Background and Objectives: Soft tissue regeneration in oral surgery has undergone remarkable progress in the last decade, supported by the development of innovative laser technologies, advanced biomaterials, platelet-rich plasma (PRP), mesenchymal stem cells (MSCs), and three-dimensional (3D) printing. Lasers are increasingly used not only for incision and coagulation but also for photobiomodulation, promoting cellular proliferation, angiogenesis, and tissue healing. The purpose of this review is to analyze the current advances in soft tissue regeneration, with a particular focus on the clinical use of lasers and their integration with other regenerative strategies. In parallel, hard tissue regeneration has evolved through the synergistic use of bioactive scaffolds, recombinant human growth factors (rhBMP-2, rhPDGF-BB), MSCs, and 3D-printed constructs. These innovations have enhanced alveolar bone regeneration, implant osseointegration, and periodontal tissue repair, offering predictable clinical outcomes. Materials and Methods: A review of the literature published between 2015 and 2025 was conducted through PubMed, Scopus, Web of Science, Embase, and Google Scholar. Clinical and preclinical studies on the use of CO2, Nd:YAG, Er:YAG, diode, and 445 nm lasers, biomaterials, PRP, MSCs, growth factors, and 3D-printed scaffolds were included. Results: Laser applications demonstrated significant benefits in epithelialization, biostimulation, and reduction in postoperative discomfort in soft tissues. For hard tissues, the combined use of MSCs, bioactive scaffolds, and growth factors promoted osteogenic differentiation, bone volume preservation, and improved mechanical stability. Photobiomodulation enhanced osteoblastic activity and accelerated bone remodeling, while 3D-printed scaffolds provided personalized architecture for optimal integration. Conclusions: Regenerative approaches integrating lasers, biomaterials, PRP, MSCs, growth factors, and 3D printing represent safe, minimally invasive, and effective strategies for the regeneration of both soft and hard oral tissues. These multidisciplinary techniques improve healing quality, functional recovery, and esthetic outcomes, reflecting the growing trend toward precision and technology-driven regenerative oral surgery.

30 May 2026 in Hygiene
Verified
Journal Article
Open access
PDF file
Andrea ScribanteAndrea Scribante
Andrea Scribante
AGAnita Groppi
Anita Groppi
PBPaolo Zampetti Branchini
Paolo Zampetti Branchini
DSDomenico Sfondrini
Domenico Sfondrini
MMMarco Monticone
Marco Monticone
Pain is a complex experience that encompasses both physical and emotional dimensions. Stomatognathic Pain (SP) affects the anatomical and functional structures of the stomatognathic system, which is involved in essential activities such as mastication, deglutition, and phonation. Consequently, SP can significantly impair patients’ quality of life, affecting physiological, psychological, and social well-being. Precision Medicine (PM) is an emerging patient-centered approach that enables healthcare providers to tailor diagnostic and therapeutic strategies according to each patient’s biochemical, physiological, environmental, and behavioral profile. The aim of this narrative review is to highlight PM tools for the diagnosis and treatment of SP and to explore their contribution to personalized management. A literature search was conducted in the PubMed and Scopus databases using the keywords “orofacial pain”, “stomatognathic pain”, “precision medicine”, “pain management”, “pain assessment”, “pain treatment”, and “patient-centered care”. Current evidence suggests that PM can improve SP management by identifying pathogenic mechanisms, clarifying disease etiology, and integrating advanced molecular and digital technologies. Emerging approaches, including genetic profiling, biomarker analysis, artificial intelligence–based diagnostics, targeted therapies, individualized rehabilitation, and behavioral interventions, may support personalized treatment and facilitate the development of patient-centered care models, ultimately reducing the burden of SP and improving clinical outcomes and quality of life.